Clinical Development

Veeva Data Cloud promises innovative, open approach

07-Apr-2020 By Jenni Spinner

The company’s Data Cloud platform is designed to increase the innovation, openness and flexibility of using patient and prescriber data.

BioData free video conferencing enables COVID-19 collaboration

06-Apr-2020 By Jenni Spinner

The company has integrated a video conferencing and documentation tool to its Labguru electronic laboratory notebook at no charge during the pandemic.

Saama launches COVID-19 data collaboration

06-Apr-2020 By Jenni Spinner

The company’s EndPandemic National Data Consortium aims to integrate data from clinical trials to accelerate development of a cure for the virus.

Science 37 guide offers COVID-19 advice for trials

06-Apr-2020 By Jenni Spinner

The whitepaper features guidance on moving forward with clinical research while working to avoid risks to patient safety and business interruption.

Advarra presents free clinical research resources during COVID-19 crisis

02-Apr-2020 By Jenni Spinner

The research consulting and solutions provider will offer complimentary transfer of IRB oversight, access to eRegulatory software and more.

FDA updates and actions on COVID-19

01-Apr-2020 By Jenni Spinner

The federal agency has announced a slew of legislation, advisory statements and other items impacting the US in the face of the pandemic.

Cloud technology launched to support remote research during the pandemic

31-Mar-2020 By Vassia Barba

Amid the spread of the pandemic, Convergency has announced the launch of a cloud-based technology platform to enable research processes to keep on going remotely.

Global Genes works to overcome barriers in rare-disease trials

31-Mar-2020 By Jenni Spinner

The company hunts for ways to improve how rare-disease patients, caregivers and advocates can connect with advancements for their condition.

Developer seeks collaborators to advance potential coronavirus treatment

30-Mar-2020 By Vassia Barba

Bold is on the hunt for supporters among the industry to help evaluate its investigational anti-cancer therapy as a potential coronavirus treatment, after seeing related elements.

Gilead rescinds request for remdesivir orphan status

30-Mar-2020 By Jenni Spinner

The pharmaceutical company has withdrawn its orphan designation request for its antiviral for the treatment of COVID-19.

Gates Foundation enlists Novartis, GSK, others in COVID-19 fight

27-Mar-2020 By Jenni Spinner

The global collaboration brings together several pharmaceutical giants to accelerate the development and delivery of coronavirus tests and therapies.

TriNetX adapts platform to answer coronavirus recruitment needs

26-Mar-2020 By Vassia Barba

TriNetX adapts its data platform to reflect the rising needs of the clinical research industry that works to fight the spread of the coronavirus pandemic with drug developments.